Kidney Damage: Link Has Been Made With an Osteoporosis Drug

There have been 16 deaths thus far relating to kidney damage, with a potential connection to a commonly prescribed osteoporosis medication The United States Food and Drug Administration (FDA), in September 2011, began notifying physicians and patients of an update to the label for Reclast (zoledronic acid) addressing the potential risk of kidney failure. Cases have been … [Read more...]